Reference health
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
not checkable · checked 2026-07-23
This work could not be checked — none of the deposited references carry a DOI. No claim is made either way about its reference list.
73 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 73 references without a DOI — listed, not checked
no DOI — not checkedRegulatory T cells in the control of immune pathology.
no DOI — not checkedImmunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
no DOI — not checkedRegulatory T cells in autoimmmunity.
no DOI — not checkedControl of regulatory T cell development by the transcription factor Foxp3.
no DOI — not checkedNatural regulatory T cells in infectious disease.
no DOI — not checkedNaturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.
no DOI — not checkedRegulatory T cells and immune tolerance.
no DOI — not checkedRegulatory T cells and cancer.
no DOI — not checkedSpecific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
no DOI — not checkedIncreased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
no DOI — not checkedPrevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
no DOI — not checkedThe expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.
no DOI — not checkedDynamics of the immune reaction to pancreatic cancer from inception to invasion.
no DOI — not checkedFrequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia.
no DOI — not checkedCD4+CD25+FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas.
no DOI — not checkedCD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.
no DOI — not checkedIntratumoral FOXP3 expression in infiltrating breast carcinoma: its association with clinicopathologic parameters and angiogenesis.
no DOI — not checkedHomeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of b16 melanoma.
no DOI — not checkedIL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.
no DOI — not checkedCD25+CD4+ regulatory T-cells in cancer.
no DOI — not checkedTumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody.
no DOI — not checkedDepletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
no DOI — not checkedEnhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.
no DOI — not checkedInduction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.
no DOI — not checkedTumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.
no DOI — not checkedTreatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
no DOI — not checkedStimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance.
no DOI — not checkedConcomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.
no DOI — not checkedSynergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.
no DOI — not checkedCyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumor: evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumor burden.
no DOI — not checkedCyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.
no DOI — not checkedMetronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients.
no DOI — not checkedCyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
no DOI — not checkedHoming to suppress: address codes for Treg migration.
no DOI — not checkedSystemic and local characterization of regulatory T cells in a chronic fungal infection in humans.
no DOI — not checkedTherapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice.
no DOI — not checkedCritical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.
no DOI — not checkedCCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence.
no DOI — not checkedCCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
no DOI — not checkedUnique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells.
no DOI — not checkedAlloantigen-enhanced accumulation of CCR5+“effector” regulatory T cells in the gravid uterus.
no DOI — not checkedThe majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors.
no DOI — not checkedCCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset.
no DOI — not checkedDistinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets.
no DOI — not checkedPrevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
no DOI — not checkedInduction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.
no DOI — not checkedIncreased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
no DOI — not checkedCre-lox-regulated conditional RNA interference from transgenes.
no DOI — not checkedDiscovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety.
no DOI — not checkedA small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.
no DOI — not checkedThe unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3.
no DOI — not checkedRegulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy.
no DOI — not checkedHost absence of CCR5 potentiates dendritic cell vaccination.
no DOI — not checkedMesenchymal stem cells within tumour stroma promote breast cancer metastasis.
no DOI — not checkedSelective infiltration of CCR5+CXCR3+ T lymphocytes in human colorectal carcinoma.
no DOI — not checkedExpression of CCL5 (RANTES) and CCR5 in prostate cancer.
no DOI — not checkedPrognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer.
no DOI — not checkedA comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.
no DOI — not checkedRole of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
no DOI — not checkedA non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses.
no DOI — not checkedA pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
no DOI — not checkedTherapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
no DOI — not checkedGenome-wide expression profiling during protection from colitis by regulatory T cells.
no DOI — not checkedEffect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice.
no DOI — not checkedA chemokine receptor antagonist inhibits experimental breast tumor growth.
no DOI — not checkedComprehensive mapping of poxvirus vCCI chemokine-binding protein: expanded range of ligand interactions and unusual dissociation kinetics.
no DOI — not checkedMembrane-bound CC chemokine inhibitor 35K provides localized inhibition of CC chemokine activity in vitro and in vivo.
no DOI — not checkedViral chemokine-binding proteins.
no DOI — not checkedCCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers.
no DOI — not checkedChemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.
no DOI — not checkedMast cells are essential intermediaries in regulatory T-cell tolerance.
no DOI — not checkedMesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer.
no DOI — not checkedMesothelin-specific CD8+ T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.4049/jimmunol.182.3.1746"><img src="https://citestamp.com/citestamped/10.4049/jimmunol.182.3.1746/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.4049/jimmunol.182.3.1746)